These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16201750)

  • 1. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
    Li J; Muscarella P; Joo SH; Knobloch TJ; Melvin WS; Weghorst CM; Tsai MD
    Biochemistry; 2005 Oct; 44(40):13246-56. PubMed ID: 16201750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
    Li J; Melvin WS; Tsai MD; Muscarella P
    Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
    Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
    EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).
    Sugimoto M; Nakamura T; Ohtani N; Hampson L; Hampson IN; Shimamoto A; Furuichi Y; Okumura K; Niwa S; Taya Y; Hara E
    Genes Dev; 1999 Nov; 13(22):3027-33. PubMed ID: 10580009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
    Li J; Joo SH; Tsai MD
    Biochemistry; 2003 Nov; 42(46):13476-83. PubMed ID: 14621993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
    Mahajan A; Guo Y; Yuan C; Weghorst CM; Tsai MD; Li J
    J Mol Biol; 2007 Nov; 373(4):990-1005. PubMed ID: 17881001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
    Li J; Li H; Tsai MD
    Biochemistry; 2003 Jun; 42(22):6921-8. PubMed ID: 12779347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
    Ceha HM; Nasser I; Medema RH; Slebos RJ
    Biochem Biophys Res Commun; 1998 Aug; 249(2):550-5. PubMed ID: 9712735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEI family of nuclear factors regulates p53-dependent transcriptional activation.
    Watanabe-Fukunaga R; Iida S; Shimizu Y; Nagata S; Fukunaga R
    Genes Cells; 2005 Aug; 10(8):851-60. PubMed ID: 16098148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of a hyperstable p16INK4a that restores Cdk4 binding activity when combined with oncogenic mutations.
    Cammett TJ; Luo L; Peng ZY
    J Mol Biol; 2003 Mar; 327(1):285-97. PubMed ID: 12614625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal domain of p16(INK4a) is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fibrosarcoma cells.
    Fahham N; Sardari S; Ostad SN; Vaziri B; Ghahremani MH
    J Cell Biochem; 2010 Dec; 111(6):1598-606. PubMed ID: 21053367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.
    Mori N; Yang R; Kawamata N; Miller CW; Mizoguchi H; Koeffler HP
    Int J Hematol; 2003 Apr; 77(3):259-62. PubMed ID: 12731669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that P12, a specific variant of P16(INK4A), plays a suppressive role in human pancreatic carcinogenesis.
    Poi MJ; Knobloch TJ; Yuan C; Tsai MD; Weghorst CM; Li J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):217-22. PubMed ID: 23727582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of p16INK4a and its interaction with CDK4.
    Yang R; Serrano M; Slater J; Leung E; Koeffler HP
    Biochem Biophys Res Commun; 1996 Jan; 218(1):254-9. PubMed ID: 8573142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR uncovers direct interaction between human NEDD4-1 and p34
    Shrestha P; Yun JH; Ko YJ; Yeon KJ; Kim D; Lee H; Jin DH; Nam KY; Yoo HD; Lee W
    Biochem Biophys Res Commun; 2017 Aug; 490(3):984-990. PubMed ID: 28666866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors.
    Yarbrough WG; Buckmire RA; Bessho M; Liu ET
    J Natl Cancer Inst; 1999 Sep; 91(18):1569-74. PubMed ID: 10491434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
    Villacañas O; Pérez JJ; Rubio-Martínez J
    J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies.
    Hong SW; Kim CJ; Park WS; Shin JS; Lee SD; Ko SG; Jung SI; Park IC; An SK; Lee WK; Lee WJ; Jin DH; Lee MS
    Cancer Res; 2009 Feb; 69(3):741-6. PubMed ID: 19176394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.